NCT00327483

Brief Summary

Information technology will be brought directly to renal transplant recipients to help them learn about the large number of medications they are required to take on a life long basis, in order to prevent errors and improve safety.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Jul 2005

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2005

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 18, 2006

Completed
Last Updated

May 18, 2006

Status Verified

May 1, 2006

First QC Date

May 16, 2006

Last Update Submit

May 16, 2006

Conditions

Renal Transplant Recipients

Keywords

TransplantMedication errorPatient SafetyInformation technology

Outcome Measures

Primary Outcomes (1)

  • Medication errors

Secondary Outcomes (4)

  • Serum creatinine

  • Rejection episodes

  • Rehospitalizations

  • Graft loss

Interventions

Internet based education softwareBEHAVIORAL

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale New Haven Hospital

New Haven, Connecticut, CT, United States

RECRUITING

Study Officials

  • Amy L Friedman, MD

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
ECT
Intervention Model
SINGLE GROUP
Sponsor Type
FED

Study Record Dates

First Submitted

May 16, 2006

First Posted

May 18, 2006

Study Start

July 1, 2005

Study Completion

April 1, 2006

Last Updated

May 18, 2006

Record last verified: 2006-05

Locations

US(1)